Evolus Dermal Filler Evolysse Lift Meets Primary Endpoint, Demonstrates Superiority To Restylane-L At 6 Months; Shows Statistically Significant Improvement In Nasolabial Fold Severity Compared To Restylane-L At All Timepoints Over 12 Months
Evolus Dermal Filler Evolysse Lift Meets Primary Endpoint, Demonstrates Superiority To Restylane-L At 6 Months; Shows Statistically Significant Improvement In Nasolabial Fold Severity Compared To Restylane-L At All Timepoints Over 12 Months
Evolus 真皮填充劑 Evolysse Lift 達到主要終點，在 6 個月時顯示出優於 Restylane-L；在 12 個月內的所有時間點上，與 Restylane-L 相比，鼻脣溝的嚴重程度在統計學上都有顯著改善
Evolus Dermal Filler Evolysse Lift Meets Primary Endpoint, Demonstrates Superiority To Restylane-L At 6 Months; Shows Statistically Significant Improvement In Nasolabial Fold Severity Compared To Restylane-L At All Timepoints Over 12 Months
Evolus 真皮填充劑 Evolysse Lift 達到主要終點，在 6 個月時顯示出優於 Restylane-L；在 12 個月內的所有時間點上，與 Restylane-L 相比，鼻脣溝的嚴重程度在統計學上都有顯著改善
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。